» Articles » PMID: 3088654

The Discriminative Stimulus and Subjective Effects of D-amphetamine, Phenmetrazine and Fenfluramine in Humans

Overview
Specialty Pharmacology
Date 1986 Jan 1
PMID 3088654
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The discriminative stimulus (DS) and subjective effects of d-amphetamine (AMP), phenmetrazine (PMT) and fenfluramine (FFL) were studied in a group of normal healthy adults. Subjects (N = 27) were trained to discriminate between placebo and 10 mg AMP (PO). Fourteen of the subjects (discriminators) reliably learned the discrimination, whereas the other 13 did not. Nearly all discriminators labelled AMP as a stimulant, and AMP, relative to placebo, increased ratings of drug liking and general activity level, and produced typical stimulant-like subjective effects, as measured by the Profile of Mood States, the Addiction Research Center Inventory, and a series of visual analog scales. The discrimination accuracy of discriminators increased as a function of hour after drug ingestion, as did analog ratings of how certain subjects were that their discrimination responses were correct. Discriminators were tested with doses of PMT (25 and 50 mg) and FFL (20 and 40 mg) to determine whether the DS properties of these drugs would substitute for those of AMP. Both doses of PMT consistently substituted for AMP, and PMT produced subjective effects very similar to those of AMP. Conversely, neither dose of FFL consistently substituted for AMP, and FFL produced essentially no subjective effects. These findings are consistent with results from discrimination studies with other species, and provide further evidence of the validity of this procedure for studying the DS properties of drugs in humans.

Citing Articles

Reinforcing effects of phenethylamine analogs found in dietary supplements.

McGriff S, Chojnacki M, Thorndike E, Rice K, Baumann M, Schindler C Psychopharmacology (Berl). 2022; 239(11):3723-3730.

PMID: 36190536 PMC: 9590234. DOI: 10.1007/s00213-022-06246-x.


Human drug discrimination: A primer and methodological review.

Bolin B, Alcorn J, Reynolds A, Lile J, Rush C Exp Clin Psychopharmacol. 2016; 24(4):214-28.

PMID: 27454673 PMC: 4965187. DOI: 10.1037/pha0000077.


Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys.

Banks M, Blough B, Fennell T, Snyder R, Negus S Drug Alcohol Depend. 2012; 130(1-3):158-66.

PMID: 23211394 PMC: 3616150. DOI: 10.1016/j.drugalcdep.2012.10.026.


The discriminative stimulus effects of tripelennamine in humans.

Johanson C, Evans S, Henningfield J Psychopharmacology (Berl). 1996; 126(2):140-6.

PMID: 8856833 DOI: 10.1007/BF02246349.


Drug discrimination by humans compared to nonhumans: current status and future directions.

Kamien J, Bickel W, Hughes J, Higgins S, Smith B Psychopharmacology (Berl). 1993; 111(3):259-70.

PMID: 7870962 DOI: 10.1007/BF02244940.


References
1.
Chait L, Uhlenhuth E, Johanson C . The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology (Berl). 1985; 86(3):307-12. DOI: 10.1007/BF00432219. View

2.
Brown C, McAllister D, Turek I . Psychomotor test performance with a fenfluramine-amphetamine combination. J Clin Pharmacol. 1974; 14(7):369-76. DOI: 10.1002/j.1552-4604.1974.tb01413.x. View

3.
Gotestam K, Gunne L . Subjective effects of two anorexigenic agents fenfluramine and AN 448 in amphetamine-dependent subjects. Br J Addict Alcohol Other Drugs. 1972; 67(1):39-44. DOI: 10.1111/j.1360-0443.1972.tb01166.x. View

4.
SCHECHTER M, ROSECRANS J . D-amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol. 1973; 21(2):212-6. DOI: 10.1016/0014-2999(73)90228-8. View

5.
Martin W, SLOAN J, SAPIRA J, Jasinski D . Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971; 12(2):245-58. DOI: 10.1002/cpt1971122part1245. View